Yikilmaz, Taha Numan, Ayhan Dirim, Ebru Sebnem Ayva, Handan Ozdemir, and Hakan Ozkardes. 2016. “Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin”. Urology Journal 13 (3):2677-83. https://doi.org/10.22037/uj.v13i3.3294.